WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...

NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...

WASHINGTON - While in Cleveland, Ohio, Attorney General Jeff Sessions today announced the unsealing of a 43-count indictment in federal court in Cleveland, which charges two Chinese citizens with operating a conspiracy that manufactured and shipped deadly fentanyl analogues and 250 other drugs to at least 25 countries and 37...

TULSA, Okla.— Special Agent in Charge Clyde E. Shelley, Jr. of the Drug Enforcement Administration and United States Attorney Trent Shores announced that a federal grand jury indicted 22 people for their roles in drug trafficking and money laundering operations that included the use of Casa Herrera, a local money...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...

SHERMAN, Texas – A jury has found two Chinese nationals guilty of maritime drug smuggling, announced Special Agent in Charge Clyde E. Shelley, Jr. of the Drug Enforcement Administration, and Eastern District of Texas U.S. Attorney Joseph D. Brown today. FeiShang Liang, 52, and KanHua Wu, 51, both of the...

OKLAHOMA CITY - Jesus Fransisco Cervantes, 31, of Oklahoma City pled guilty today to conspiring to possess methamphetamine with intent to distribute, announced Special Agent-in-Charge Clyde E. Shelley, Jr. of the DEA and Robert J. Troester, Acting United States Attorney for the Western District of Oklahoma. A federal grand jury...

WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...